Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nahdi Medical CoSAU:4164 -0.47%56 PB Ratio is 4.75 as of Aug. 05, 2026, which is 36% below its 10-year median of 7.41. GuruFocus rates SAU:4164 with a GF Score™ of 56/100 and a GF Value™ of ﷼141.25 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 607 Healthcare Providers & Services companies, Nahdi Medical Co ranks worse than 79.74% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-08-05), Nahdi Medical Co's share price is ﷼95.55. Nahdi Medical Co's Book Value per Share for the quarter that ended in Mar. 2026 was ﷼20.12. Hence, Nahdi Medical Co's PB Ratio of today is 4.75.
Good Sign:
Nahdi Medical Co stock PB Ratio (=4.53) is close to 5-year low of 4.35.
The historical rank and industry rank for Nahdi Medical Co's PB Ratio or its related term are showing as below:
SAU:4164'
s PB Ratio Range Over the Past 10 Years
Min: 4.35 Med: 7.41 Max: 12.53
Current: 4.75
During the past 5 years, Nahdi Medical Co's highest PB Ratio was 12.53. The lowest was 4.35. And the median was 7.41.
SAU:4164's PB Ratio is ranked worse than 79.74% of 607
companies
in the Healthcare Providers & Services industry
Industry Median: 2.04
vs SAU:4164: 4.75
During the past 12 months, Nahdi Medical Co's average Book Value Per Share Growth Rate was 6.80% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 6.90% per year.
During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of Nahdi Medical Co was 17.30% per year. The lowest was 6.90% per year. And the median was 12.10% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Nahdi Medical Co PB Ratio Related Terms
Nahdi Medical Co PB Ratio Historical Data
* Premium members only.
The historical data trend for Nahdi Medical Co's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Nahdi Medical Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nahdi Medical Co PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nahdi Medical Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Nahdi Medical Co's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Nahdi Medical Co (SAU:4164) has a PB Ratio of 4.75 as of Aug. 05, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Nahdi Medical Co and its competitors. This is 36% below median its historical median of 7.41. Over the past decade, Nahdi Medical Co's PB Ratio has ranged from 4.35 to 12.53. According to the industry distribution chart, Nahdi Medical Co ranks #484 out of 607 companies in the Healthcare Providers & Services industry, placing it in the top 79.7%.
Is Nahdi Medical Co's PB Ratio too high?
Nahdi Medical Co's current PB Ratio of 4.75 is 36% below median its 10-year median of 7.41. Over the past 10 years, this metric has ranged from a low of 4.35 to a high of 12.53. The Healthcare Providers & Services industry median PB Ratio is 2.04. Nahdi Medical Co's value of 4.75 is 132.8% above this industry median. Based on the distribution chart, Nahdi Medical Co ranks #484 out of 607 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Nahdi Medical Co has a GF Score™ of 56/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nahdi Medical Co's PB Ratio compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Nahdi Medical Co ranks #484 out of 607 companies for PB Ratio. This places Nahdi Medical Co in the lower half of its industry. The industry median PB Ratio is 2.04. Nahdi Medical Co's value of 4.75 is 132.8% above this benchmark. Historically, Nahdi Medical Co's own PB Ratio has ranged from 4.35 to 12.53 over the past decade. While the company's 10-year median is 7.41 vs. the industry median of 2.04, Nahdi Medical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 2.04, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nahdi Medical Co's current PB Ratio of 4.75 is 132.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Nahdi Medical Co and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 2.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nahdi Medical Co's current PB Ratio is 4.75, which is 36% below median its own 10-year median of 7.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nahdi Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Nahdi Medical Co (SAU:4164) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼141.25, compared to a current price of ﷼95.55 — trading 32.4% below its estimated fair value. The current PB Ratio is 4.75, which is 36% below median its 10-year median of 7.41 and 132.8% above the Healthcare Providers & Services industry median of 2.04. Nahdi Medical Co's overall GF Score™ is 56/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Nahdi Medical Co (SAU:4164), the current PB Ratio is 4.75 as of Aug. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nahdi Medical Co (SAU:4164) Overvalued in 2026?
Based on GuruFocus' analysis, Nahdi Medical Co stock appears to be undervalued.
The current stock price of ﷼95.55 is trading 32.4% below its estimated GF Value™ of ﷼141.25.
GuruFocus considers Nahdi Medical Co to be Significantly Undervalued.
Key valuation signals for SAU:4164:
PB Ratio: 4.75 (36% below median its 10-year median of 7.41)
GF Value™: ﷼141.25 vs. price of ﷼95.55 (32.4% below fair value)
Industry Position: 132.8% above the Healthcare Providers & Services median (#484 of 607)
No single metric tells the full story. See the SAU:4164 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nahdi Medical Co is engaged in the wholesale and retail trading of cosmetics, pharmaceutical products, special and healthy foods, and medical equipment. It has two operating segments: Front Shop and Pharma.
56GF Score
Get the complete analysis for SAU:4164
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4164 has been successfully added to your 
